Seminars in Thrombosis and Hemostasis

Papers
(The TQCC of Seminars in Thrombosis and Hemostasis is 7. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-06-01 to 2025-06-01.)
ArticleCitations
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues55
55
44
Protamine—The Journey from DNA to Heparin Neutralization to Gene therapy44
Effects of Inflammation on Hemostasis in Acutely Ill Patients with Liver Disease39
Cancer-Associated Thrombosis: Implications toward Health-Related Quality of Life35
The Next, Next-Generation of Sequencing, Promising to Boost Research and Clinical Practice31
Thrombosis in Antiphospholipid Syndrome: Current Perspectives and Challenges in Laboratory Testing for Antiphospholipid Antibodies28
Thrombotic Antiphospholipid Syndrome and Direct Oral Anticoagulants: Unmet Needs and Review of the Literature27
Hemostatic Manifestations of Invasive Fungal Infections: A Comprehensive Review of Pathophysiological Mechanisms in Sepsis-Induced Hemostatic Disturbances, with a Focus on the Neonatal Population26
2021 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards26
Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: The Last 10 Years25
Drug–Drug Interactions in the Treatment of Cancer-Associated Venous Thromboembolism with Direct Oral Anticoagulants24
Fright of Long-Haul Flights: Focus on Travel-Associated Thrombosis24
Role of Platelets in Rheumatic Chronic Autoimmune Inflammatory Diseases24
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Comment23
Resonant Acoustic Rheometry to Measure Coagulation Kinetics in Hemophilia A and Healthy Plasma: A Novel Viscoelastic Method23
Platelet Activation and Thrombosis in COVID-1922
Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More22
Enhanced Half-Life Recombinant Factor VIII Concentrates for Hemophilia A: Final Results from Extension Studies22
Tissue Plasminogen Activator in Central Nervous System Physiology and Pathology: From Synaptic Plasticity to Alzheimer's Disease21
Arterial Thrombosis in Cancer Patients: An Update21
Platelet Function Testing: Update and Future Directions21
Testing for Lupus Anticoagulants20
Cardiovascular Mortality after Venous Thromboembolism: A Meta-Analysis of Prospective Cohort Studies19
Editorial Compilation—XIII19
Evolving Knowledge on Primary and Secondary Prevention of Venous Thromboembolism in Carriers of Hereditary Thrombophilia: A Narrative Review19
Autoantibodies in Autoimmune Coagulation Factor Deficiencies: A Review of Inhibitory and Clearance-Accelerating Mechanisms from Japanese Practice19
Fifty Years of Fibrinogen Structure and Function19
Anti-platelet Factor 4 Antibody-Mediated Disorders: An Updated Narrative Review18
Modulating Immune Responses: The Double-Edged Sword of Platelet CD40L18
Gene Therapy for Hemophilia B: Achievements, Open Issues, and Perspectives18
How Do Laboratories Perform von Willebrand Disease Diagnostics and Classification of von Willebrand Disease Patients? Results from External Quality Data and an International Survey17
Erratum: Arterial Thrombosis in Patients with Antiphospholipid Syndrome: A Review and Meta-Analysis17
Pulmonary Embolism in Patients with COVID-19: Comparison between Different Care Settings17
The History of Rare Bleeding Disorders17
Anti-Xa Monitoring of Low-Molecular-Weight Heparin during Pregnancy: A Systematic Review16
16
Comprehensive Mendelian Randomization Analysis of Smoking and Its Effects on Venous Thromboembolism15
2022 Eberhard F. Mammen Award Announcements: Part I—Most Popular Articles15
Cardiovascular and Thromboembolic Diseases in Oncology: Novel Aspects and Revisited Issues15
Toward 50 Years of Seminars in Thrombosis and Hemostasis15
Magnetic Resonance Screening for Cerebral Venous Sinus Thrombosis during Treatment with Pegaspargase14
Association between Severe Acute Respiratory Syndrome Coronavirus 2 Infection (Coronavirus Disease 2019) and Lupus Anticoagulant-Hypoprothrombinemia Syndrome: A Case Report and Literature Assessment14
Bernard–Soulier Syndrome: A Review of Epidemiology, Molecular Pathology, Clinical Features, Laboratory Diagnosis, and Therapeutic Management14
Celebrating 50 Years of Seminars in Thrombosis and Hemostasis—Part III14
Neurocoagulation from a Mechanistic Point of View in the Central Nervous System14
From Ink Pens to Computers: A Personal Look Back at Landmark Changes during 5 Decades as a Clinical Laboratory Scientist in U.S. Hemostasis Laboratories13
50 Years of Pediatric Hemostasis: Knowledge, Diagnosis, and Treatment13
13
Investigating a Signal of Acquired Hemophilia Associated with COVID-19 Vaccination: A Systematic Case Review13
The Growing Impact of Cardiovascular Oncology: Epidemiology and Pathophysiology12
Mendelian Randomization Provides No Evidence for the Bidirectional Relationship between Type 2 Diabetes and Venous Thromboembolism in East Asians and African Americans12
12
Strength of Anticoagulation in Moderate to Severe COVID-19 Illness: In Medio Stat Virtus?12
Emicizumab in Type 3 von Willebrand Disease: Report of a Case with an Alloantibody and Literature Review12
In Search of the Perfect Thrombosis and Bleeding-Associated Cancer Scale12
Automation in Platelet Function Testing: Current Challenges and Future Directions12
Laboratory Testing for the Evaluation of Phenotypic Activated Protein C Resistance12
External Quality Assessment Data for Investigation of von Willebrand Disease: Focus on Relative Utility of Contemporary Functional von Willebrand Factor Assays. The United Kingdom National External Qu12
ROTEM Testing for Direct Oral Anticoagulants11
11
Neutrophil Extracellular Traps: At the Interface of Thrombosis and Comorbidities11
International Council for Standardization in Haematology Guidance for New Lot Verification of Coagulation Reagents, Calibrators, and Controls11
Venous Thromboembolism in Children: The Rivaroxaban Experience11
The Biological Significance of von Willebrand Factor O-Linked Glycosylation11
Heparin-Like Anticoagulant: First Case Described in a Metastatic Biliopancreatic Cancer11
Colchicine as a Modulator of Platelet Function: A Systematic Review11
Gene Therapy in Hemophilia A: Achievements, Challenges, and Perspectives11
Why “the Love of Blood” in Hemophilia?11
A Brief History of Hemostasis and Thrombosis at the Mayo Clinic11
Optimizing Venous Stenting: Consensus Recommendations for Enhanced Management of Lower Extremity Deep Vein Thrombosis11
Clinical, Laboratory, and Molecular Aspects of Factor V Deficiency10
Mortality from Pulmonary Embolism in Patients with Post-Coronavirus Disease Syndrome10
Dosing Intensity of Anticoagulants for the Prevention and Treatment of Venous Thromboembolism and the Prevention of Stroke in Atrial Fibrillation: Why is There a Difference?10
Pulmonary Embolism-Related Mortality in Femur Fracture Patients: A Recent Retrospective Epidemiological Analysis10
Tranexamic Acid and Its Potential Anti-Inflammatory Effect: A Systematic Review10
A Historical Perspective on the Reversal of Anticoagulants10
Risk Factors for Left Ventricular Thrombus Formation in Patients with Dilated Cardiomyopathy10
Comparison of Platelet Function Tests for Long-Term Cardiovascular Events after Percutaneous Coronary Interventions10
Bleeding Scoring Systems in Neonates: A Systematic Review10
The Erythrocyte–ROS Axis in Thrombosis and Hemostasis10
Editorial Compilation XIV10
COVID-19 Vaccine-Associated Immune Thrombosis and Thrombocytopenia (VITT): Diagnostic Discrepancies and Global Implications10
Impact of Hematocrit on Coagulation Measured by Rotational Thromboelastometry in Healthy Subjects and Patients with Polycythemia10
Venous Thromboembolism Risk and Thromboprophylaxis in Pediatric Neurosurgery and Spinal Injury: Current Trends and Literature Review10
Cancer-Associated Thrombosis and Beyond: Biomarkers, Treatments, and Cancer-Hemostasis Interactions9
Past, Present, and Future Perspectives of Plasminogen Activator Inhibitor 1 (PAI-1)9
Evaluating Diagnostic Algorithms for Heparin-Induced Thrombocytopenia using Two Combined Automated Rapid Immunoassays9
The Applicability of Thromboelastography in Acute Ischemic Stroke: A Literature Review9
Editorial Compilation XI9
The Pathophysiological Role of Platelet-Derived Extracellular Vesicles9
Pleiotropic Effects of Heparin and its Monitoring in the Clinical Practice9
A Perspective on How Fibrinaloid Microclots and Platelet Pathology May be Applied in Clinical Investigations9
9
9
Clinical Features of Antiphospholipid Syndrome with Intracardiac Mass9
Activated Partial Thromboplastin Time and Prothrombin Time Mixing Studies: Current State of the Art9
Platelet Physiology9
Hematohidrosis in 15th Century Renaissance Art and a Review of Modern Literature9
Precision Medicine in Rare Bleeding Disorders9
NETosis in Acute Thrombotic Disorders8
Current Diagnosis of von Willebrand Disease in Italy: 3 Years Following the Release of the International Guidelines8
Safety and Efficacy of Therapeutic Anticoagulation with Subcutaneous Unfractionated Heparin in Patients with Renal Failure8
Advances in the Management of Coagulopathy in Trauma: The Role of Viscoelastic Hemostatic Assays across All Phases of Trauma Care8
Factor Replacement Treatment for Hemophilia A: Achievements and Perspectives8
Thrombin Generation Assays: What are the Current Clinical Applications?8
National Early Warning Score-2 for Identification of Patients with Intermediate-High-Risk Pulmonary Embolism8
Increased HDL-C Values and Mortality: Revolutionizing a Historical Paradigm?8
The Role of Platelets in Atherosclerosis: A Historical Review8
Hemostasis Testing in the Emergency Department: A Narrative Review8
Non-factor Therapies for Hemophilia: Achievements and Perspectives8
Molecular Mimicry between hPF4 and SARS-CoV-2 Spike Protein: Response to Comment8
Emerging Use of Viscoelastography in Thrombosis and Hemostasis: A Challenge to Conventional Coagulation Tests? Part I: The Use of Thromboelastography and Thromboelastometry in the Assessment of Hemost8
Laboratory Testing for ADAMTS13 for Thrombotic Thrombocytopenia Purpura and Beyond7
D-dimers—“Normal” Levels versus Elevated Levels Due to a Range of Conditions, Including “D-dimeritis,” Inflammation, Thromboembolism, Disseminated Intravascular Coagulation, and COVID-197
Discordant High Activated Partial Thromboplastin Time Relative to Anti-Xa Values in Hospitalized Patients is an Independent Risk Factor for Increased 30-day Mortality7
Next-Generation Sequencing and Emerging Technologies*7
Application of Activators Ecarin and Factor Xa in Thrombelastography for Measurement of Anticoagulant Effect of Direct Oral Anticoagulants Using TEG 50007
Crucial Stepping Stones in Platelet History7
2022 Eberhard F. Mammen Award Announcements: Part II—Young Investigator Awards7
One Hundred Years of Congenital Fibrinogen Disorders7
Why Does Rivaroxaban Not Work in Severe Mitral Stenosis?7
The More Recent History of Hemophilia Treatment7
7
Type 2A and 2M von Willebrand Disease: Differences in Phenotypic Parameters According to the Affected Domain by Disease-Causing Variants and Assessment of Pathophysiological Mechanisms7
Evolution of Antiphospholipid Syndrome7
PFA-100 System: A New Method for Assessment of Platelet Dysfunction7
7
7
Laboratory Testing for Fibrinogen Disorders: From Routine Investigations to Research Studies7
Internal Quality Control in Hemostasis Assays7
0.2547709941864